When are precautions for patent foramen ovale (PFO) indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patent Foramen Ovale (PFO) Precautions: Indications and Management

PFO precautions are primarily indicated for patients aged 60 years or younger with cryptogenic stroke or transient ischemic attack (TIA) where the PFO is determined to be the most likely cause of the event after thorough evaluation. 1

Specific Indications for PFO Precautions

Cryptogenic Stroke/TIA

  • PFO precautions and consideration for closure are indicated when ALL of the following criteria are met:
    • Age 18-60 years
    • Confirmed non-lacunar embolic ischemic stroke or TIA with positive neuroimaging or cortical symptoms
    • PFO determined to be the most likely cause after thorough evaluation excluding alternate etiologies 1
    • Higher likelihood of PFO causality with:
      • RoPE score >8 (includes younger age, absence of vascular risk factors) 1
      • Presence of atrial septal aneurysm or substantial shunt size (grade 3) 1

High-Risk Occupations

  • PFO precautions should be considered for:
    • High-volume divers
    • Compressed-air tunnel workers
    • High-altitude aviators
    • Astronauts
    • Particularly those with multiple recurrences of decompression sickness or asymptomatic neurological events 1

Right-Sided Cardiac Disease

  • Patients with right-sided cardiac disease and elevated right-sided filling pressures are predisposed to right-to-left shunting through PFO
  • Precautions should be individualized based on severity of right-to-left shunting 1

Peripheral Embolism

  • Precautions should be considered for patients with confirmed peripheral embolism attributed to paradoxical embolization through PFO 1

Management Approach Based on Patient Characteristics

For Patients ≤60 Years with Cryptogenic Stroke/TIA and PFO

  1. Device closure plus antiplatelet therapy is recommended if:

    • PFO is determined to be the most likely cause of stroke/TIA
    • Patient has high-risk PFO features (atrial septal aneurysm, large shunt)
    • No other indication for chronic anticoagulation exists 1
  2. Antiplatelet therapy alone if:

    • Patient declines PFO closure
    • No other indication for anticoagulation exists 1
  3. Anticoagulation therapy if:

    • Separate evidence-based indication for anticoagulation exists
    • Decision regarding PFO closure should be individualized based on risk/benefit profile 1

For Patients >60 Years with Stroke/TIA and PFO

  • PFO closure is NOT recommended 1, 2
  • Antiplatelet therapy alone is recommended unless there is a separate indication for anticoagulation 1
  • PFO in this population is more likely incidental rather than causal 2

For Patients with Incidentally Found PFO (No Stroke History)

  • No specific precautions or interventions recommended 2
  • Routine surveillance imaging is not recommended 2

Diagnostic Evaluation for PFO-Related Events

  • Transesophageal echocardiography (TEE) is preferred over transthoracic echocardiography for PFO detection 1
  • Saline contrast with Valsalva maneuver increases sensitivity for PFO detection 1
  • Complete evaluation should exclude:
    • Atrial fibrillation (prolonged rhythm monitoring)
    • Aortic atherothrombosis or left atrial clot (TEE or alternative imaging)
    • Cerebrovascular disease (carotid ultrasonography, CT, or MRI) 1

Common Pitfalls to Avoid

  • Recommending PFO closure in patients >60 years despite lack of proven benefit 2
  • Assuming PFO causality in older patients when it's more likely incidental 2
  • Neglecting thorough evaluation for other stroke etiologies 2
  • Overtreatment of incidentally found PFOs without history of cryptogenic stroke 2
  • Failing to recognize that small PFOs carry lower risk than those with large shunts or associated atrial septal aneurysms 2

Monitoring After PFO Detection

  • For patients with cryptogenic stroke/TIA and PFO who undergo closure:

    • Monitor for potential complications including atrial fibrillation (occurs in approximately 4.6% of patients) 1
    • Continue antiplatelet therapy post-closure 1
  • For patients with cryptogenic stroke/TIA and PFO managed medically:

    • Regular neurological follow-up to monitor for recurrent symptoms
    • Comprehensive vascular risk factor management 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Patent Foramen Ovale in Patients with Transient Ischemic Attack

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.